-
1
-
-
63449118087
-
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program
-
Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531-43. doi: 10.1002/cncr.24121.
-
(2009)
Cancer
, vol.115
, pp. 1531-1543
-
-
Mirabello, L.1
Troisi, R.J.2
Savage, S.A.3
-
2
-
-
18044362296
-
Sarcomas in adolescents and young adults: a summary of a recent symposium
-
Herzog CE. Sarcomas in adolescents and young adults: a summary of a recent symposium. J Pediatr Hematol Oncol. 2005;27:177-8.
-
(2005)
J Pediatr Hematol Oncol
, vol.27
, pp. 177-178
-
-
Herzog, C.E.1
-
3
-
-
47149105458
-
Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics
-
Chua I, Quinti I, Grimbacher B. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol. 2008;15:368-74. doi: 10.1097/MOH.0b013e328302c7b6.
-
(2008)
Curr Opin Hematol
, vol.15
, pp. 368-374
-
-
Chua, I.1
Quinti, I.2
Grimbacher, B.3
-
4
-
-
58149166856
-
EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases
-
Sarcoma
-
Moore Dalal K, Antonescu CR, Dematteo RP, Maki RG. EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases. Sarcoma. 2008:859407. doi: 10.1155/2008/859407.
-
(2008)
-
-
Moore Dalal, K.1
Antonescu, C.R.2
Dematteo, R.P.3
Maki, R.G.4
-
5
-
-
67650381830
-
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers
-
Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, et al. Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers. Clin Cancer Res. 2009;15:4277-87. doi: 10.1158/1078-0432.CCR-09-0537.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4277-4287
-
-
Carpenter, E.L.1
Mick, R.2
Rech, A.J.3
Beatty, G.L.4
Colligon, T.A.5
Rosenfeld, M.R.6
-
6
-
-
34848819211
-
Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment
-
Gajewski TF. Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res. 2007;13:5256-61.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 5256-5261
-
-
Gajewski, T.F.1
-
7
-
-
46849090082
-
Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients
-
Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Cancer Immun. 2008;8:10.
-
(2008)
Cancer Immun
, vol.8
, pp. 10
-
-
Bose, A.1
Chakraborty, T.2
Chakraborty, K.3
Pal, S.4
Baral, R.5
-
8
-
-
66849124862
-
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
-
Berghuis D, de Hooge AS, Santos SJ, Horst D, Wiertz EJ, van Eggermond MC, et al. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. J Pathol. 2009;218:222-31.
-
(2009)
J Pathol
, vol.218
, pp. 222-231
-
-
Berghuis, D.1
Hooge, A.S.2
Santos, S.J.3
Horst, D.4
Wiertz, E.J.5
Eggermond, M.C.6
-
9
-
-
67650091383
-
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease
-
Brinkrolf P, Landmeier S, Altvater B, Chen C, Pscherer S, Rosemann A, et al. A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int J Cancer. 2009;125:879-96.
-
(2009)
Int J Cancer
, vol.125
, pp. 879-896
-
-
Brinkrolf, P.1
Landmeier, S.2
Altvater, B.3
Chen, C.4
Pscherer, S.5
Rosemann, A.6
-
10
-
-
2942752408
-
Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis
-
Ackermann B, Tröger A, Glouchkova L, Körholz D, Göbel U, Dilloo D. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin Padiatr. 2004;216:176-82.
-
(2004)
Klin Padiatr
, vol.216
, pp. 176-182
-
-
Ackermann, B.1
Tröger, A.2
Glouchkova, L.3
Körholz, D.4
Göbel, U.5
Dilloo, D.6
-
11
-
-
50649111902
-
Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity
-
Guo W, Guo Y, Tang S, Qu H, Zhao H. Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity. Clin Orthop Relat Res. 2008;466:2176-83.
-
(2008)
Clin Orthop Relat Res
, vol.466
, pp. 2176-2183
-
-
Guo, W.1
Guo, Y.2
Tang, S.3
Qu, H.4
Zhao, H.5
-
12
-
-
0035576891
-
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
-
Geiger JD, Hutchinson RJ, Hohenkirk LF, McKenna EA, Yanik GA, Levine JE, et al. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res. 2001;61:8513-9.
-
(2001)
Cancer Res
, vol.61
, pp. 8513-8519
-
-
Geiger, J.D.1
Hutchinson, R.J.2
Hohenkirk, L.F.3
McKenna, E.A.4
Yanik, G.A.5
Levine, J.E.6
-
13
-
-
0036179943
-
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study
-
Dagher R, Long LM, Read EJ, Leitman SF, Carter CS, Tsokos M, et al. Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study. Med Pediatr Oncol. 2002;38:158-64.
-
(2002)
Med Pediatr Oncol
, vol.38
, pp. 158-164
-
-
Dagher, R.1
Long, L.M.2
Read, E.J.3
Leitman, S.F.4
Carter, C.S.5
Tsokos, M.6
-
14
-
-
51049105734
-
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
-
Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, et al. A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res. 2008;14:4850-8.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4850-4858
-
-
Mackall, C.L.1
Rhee, E.H.2
Read, E.J.3
Khuu, H.M.4
Leitman, S.F.5
Bernstein, D.6
-
15
-
-
31944438409
-
Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples
-
Appay V, Reynard S, Voelter V, Romero P, Speiser DE, Leyvraz S. Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Immunol Methods. 2006;309:192-9.
-
(2006)
J Immunol Methods
, vol.309
, pp. 192-199
-
-
Appay, V.1
Reynard, S.2
Voelter, V.3
Romero, P.4
Speiser, D.E.5
Leyvraz, S.6
-
16
-
-
78349293679
-
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
-
Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol. 2010;12:631-44.
-
(2010)
Neuro Oncol
, vol.12
, pp. 631-644
-
-
Gustafson, M.P.1
Lin, Y.2
New, K.C.3
Bulur, P.A.4
O'Neill, B.P.5
Dietz, A.B.6
-
17
-
-
84921439290
-
Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity
-
Chavan R, Salvador D, Gustafson MP, Dietz AB, Nevala W, Markovic SN. Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity. Cancer Immunol Res. 2014;2:241-8.
-
(2014)
Cancer Immunol Res
, vol.2
, pp. 241-248
-
-
Chavan, R.1
Salvador, D.2
Gustafson, M.P.3
Dietz, A.B.4
Nevala, W.5
Markovic, S.N.6
-
18
-
-
84991030323
-
Immune monitoring using the predictive power of immune profiles
-
Gustafson MP, Lin Y, LaPlant B, Liwski CJ, Maas ML, League SC, et al. Immune monitoring using the predictive power of immune profiles. J ImmunoTher Cancer. 2013;1:7.
-
(2013)
J ImmunoTher Cancer
, vol.1
, pp. 7
-
-
Gustafson, M.P.1
Lin, Y.2
LaPlant, B.3
Liwski, C.J.4
Maas, M.L.5
League, S.C.6
-
19
-
-
84925740519
-
A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans
-
Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnson P, Peikert T, et al. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015;10, e0121546.
-
(2015)
PLoS One
, vol.10
-
-
Gustafson, M.P.1
Lin, Y.2
Maas, M.L.3
Keulen, V.P.4
Johnson, P.5
Peikert, T.6
-
20
-
-
78751689059
-
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma
-
Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood. 2011;117:872-81.
-
(2011)
Blood
, vol.117
, pp. 872-881
-
-
Lin, Y.1
Gustafson, M.P.2
Bulur, P.A.3
Gastineau, D.A.4
Witzig, T.E.5
Dietz, A.B.6
-
21
-
-
84857034835
-
Association of an increased frequency of CD14(+) HLA-DR(lo/neg) monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)
-
Gustafson MP, Abraham RS, Lin Y, Wu W, Gastineau DA, Zent CS, et al. Association of an increased frequency of CD14(+) HLA-DR(lo/neg) monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL). Br J Haematol. 2012;156:674-6.
-
(2012)
Br J Haematol
, vol.156
, pp. 674-676
-
-
Gustafson, M.P.1
Abraham, R.S.2
Lin, Y.3
Wu, W.4
Gastineau, D.A.5
Zent, C.S.6
-
22
-
-
76149145359
-
Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer
-
Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, et al. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate. 2010;70:443-55.
-
(2010)
Prostate
, vol.70
, pp. 443-455
-
-
Vuk-Pavlovic, S.1
Bulur, P.A.2
Lin, Y.3
Qin, R.4
Szumlanski, C.L.5
Zhao, X.6
-
23
-
-
84942909842
-
Intratumoral CD14+ cells and circulating CD4+HLA-DRlo/neg monocytes correlate with decreased survival in patients with clear cell renal cell carcinoma
-
epub ahead of print
-
Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, et al. Intratumoral CD14+ cells and circulating CD14+HLA-DRlo/neg monocytes correlate with decreased survival in patients with clear cell renal cell carcinoma. Clin Cancer Res. 2015;epub ahead of print.
-
(2015)
Clin Cancer Res
-
-
Gustafson, M.P.1
Lin, Y.2
Bleeker, J.S.3
Warad, D.4
Tollefson, M.K.5
Crispen, P.L.6
-
24
-
-
0242550686
-
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
-
Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973-80.
-
(2003)
J Allergy Clin Immunol
, vol.112
, pp. 973-980
-
-
Shearer, W.T.1
Rosenblatt, H.M.2
Gelman, R.S.3
Oyomopito, R.4
Plaeger, S.5
Stiehm, E.R.6
-
25
-
-
0030728995
-
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations
-
Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pedatr. 1997;130:388-93.
-
(1997)
J Pedatr
, vol.130
, pp. 388-393
-
-
Comans-Bitter, W.M.1
Groot, R.2
Beemd, R.3
Neijens, H.J.4
Hop, W.C.5
Groeneveld, K.6
-
26
-
-
84919842174
-
Lymphocytes subsets reference values in childhood
-
Tosato F, Bucciol G, Pantano G, Putti MC, Sanzari MC, Basso G, et al. Lymphocytes subsets reference values in childhood. Cytometry A. 2015;87:81-5.
-
(2015)
Cytometry A
, vol.87
, pp. 81-85
-
-
Tosato, F.1
Bucciol, G.2
Pantano, G.3
Putti, M.C.4
Sanzari, M.C.5
Basso, G.6
-
27
-
-
84857479028
-
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
-
Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, et al. Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas. BMC Clin Pathol. 2012;12:5.
-
(2012)
BMC Clin Pathol
, vol.12
, pp. 5
-
-
Sorbye, S.W.1
Kilvaer, T.K.2
Valkov, A.3
Donnem, T.4
Smeland, E.5
Al-Shibli, K.6
-
28
-
-
33846445664
-
Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma
-
De Angulo G, Hernandez M, Morales-Arias J, Herzog CE, Anderson P, Wolff J, et al. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. J Pediatr Hematol Oncol. 2007;29:48-52.
-
(2007)
J Pediatr Hematol Oncol
, vol.29
, pp. 48-52
-
-
Angulo, G.1
Hernandez, M.2
Morales-Arias, J.3
Herzog, C.E.4
Anderson, P.5
Wolff, J.6
-
29
-
-
77954695842
-
Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma
-
Moore C, Eslin D, Levy A, Roberson J, Giusti V, Sutphin R. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma. Pediatr Blood Cancer. 2010;55.
-
(2010)
Pediatr Blood Cancer
, Issue.55
-
-
Moore, C.1
Eslin, D.2
Levy, A.3
Roberson, J.4
Giusti, V.5
Sutphin, R.6
-
30
-
-
34247595587
-
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma
-
Merchant MS, Melchionda F, Sinha M, Khanna C, Helman L, Mackall CL. Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother. 2007;56:1037-46.
-
(2007)
Cancer Immunol Immunother
, vol.56
, pp. 1037-1046
-
-
Merchant, M.S.1
Melchionda, F.2
Sinha, M.3
Khanna, C.4
Helman, L.5
Mackall, C.L.6
-
31
-
-
27144458821
-
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
-
Contardi E, Palmisano GL, Tazzari PL, Martelli AM, Falà F, Fabbi M, et al. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer. 2005;117:538-50.
-
(2005)
Int J Cancer
, vol.117
, pp. 538-550
-
-
Contardi, E.1
Palmisano, G.L.2
Tazzari, P.L.3
Martelli, A.M.4
Falà, F.5
Fabbi, M.6
-
32
-
-
82955170680
-
Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma
-
Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, et al. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol. 2011;30:1051-5.
-
(2011)
DNA Cell Biol
, vol.30
, pp. 1051-1055
-
-
Liu, Y.1
He, Z.2
Feng, D.3
Shi, G.4
Gao, R.5
Wu, X.6
-
33
-
-
84872787611
-
Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma
-
Kawano M, Itonaga I, Iwasaki T, Tsumura H. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma. Oncol Rep. 2013;29:1001-6.
-
(2013)
Oncol Rep
, vol.29
, pp. 1001-1006
-
-
Kawano, M.1
Itonaga, I.2
Iwasaki, T.3
Tsumura, H.4
-
34
-
-
84900839768
-
Cancer vaccines in the world of immune suppressive monocytes (CD14+HLA-DRlo/neg cells): the gateway to improved responses
-
Laborde RR, Lin Y, Gustafson MP, Bulur P, Dietz AB. Cancer vaccines in the world of immune suppressive monocytes (CD14+HLA-DRlo/neg cells): the gateway to improved responses. Front Immunol. 2014;5:147. doi: 10.3389/fimmu.2014.00147.
-
(2014)
Front Immunol
, vol.5
, pp. 147
-
-
Laborde, R.R.1
Lin, Y.2
Gustafson, M.P.3
Bulur, P.4
Dietz, A.B.5
-
35
-
-
34447258415
-
Identification of a new subset of myeloid suppressor cells in pheripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine
-
Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, et al. Identification of a new subset of myeloid suppressor cells in pheripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol. 2007;25:2546-53.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2546-2553
-
-
Filipazzi, P.1
Valenti, R.2
Huber, V.3
Pilla, L.4
Canese, P.5
Iero, M.6
-
36
-
-
77953141534
-
Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
-
Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010;70:4335-45. doi: 10.1158/0008-5472.
-
(2010)
Cancer Res
, vol.70
, pp. 4335-4345
-
-
Poschke, I.1
Mougiakakos, D.2
Hansson, J.3
Masucci, G.V.4
Kiessling, R.5
-
37
-
-
84873569840
-
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
-
Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, et al. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia. 2013;27:377-88.
-
(2013)
Leukemia
, vol.27
, pp. 377-388
-
-
Mougiakakos, D.1
Jitschin, R.2
Bahr, L.3
Poschke, I.4
Gary, R.5
Sundberg, B.6
-
38
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Engl J Med
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363.
-
(2010)
, pp. 363
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
-
39
-
-
84879759020
-
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
-
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013;369:134-44.
-
(2013)
N Engl J Med
, vol.369
, pp. 134-144
-
-
Hamid, O.1
Robert, C.2
Daud, A.3
Hodi, F.S.4
Hwu, W.J.5
Kefford, R.6
|